Astrazeneca PLC ORD SHS $0.25
Astrazeneca PLC ORD SHS $0.25/ GB0009895292 /
AZN
|
13.05.2024 09:27:08
|
Zm.
+24,0000
|
Wolumen |
Bid09:27:12 |
Ask09:27:12 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
|
12 394,0000GBX
|
+0,19%
|
79 460
Obrót(GBP): 9,73 mln |
12 394,0000Wolumen Bid: 93 |
12 398,0000Wolumen Ask: 220 |
192,32 mldGBP |
- |
- |
Opis działalności
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Zarząd & Rada nadzorcza
| CEO |
| Pascal Soriot |
| Zarząd |
| Aradhana Sarin, Pam Cheng, Ruud Dobber, Marc Dunoyer, David Fredrickson, Susan Galbraith, Menelas (Mene) Pangalos, Jeff Pott, Iskra Reic, Leon Wang, Sharon Barr |
| Rada nadzorcza |
| Michel Demaré, Pascal Soriot, Aradhana Sarin, Philip Broadley, Euan Ashley, Deborah DiSanzo, Diana Layfield, Sheri McCoy, Tony Mok, Nazneen Rahman, Andreas Rummelt, Marcus Wallenberg |
Dane firmy
| Nazwa: |
AstraZeneca plc |
| Adres: |
1 Francis Crick Avenue Cambridge Biomedical Campus,Cambridge, CB2 0AA United Kingdom |
| Telefon: |
0800 783 0033 |
| Fax: |
+44-20-7604-8151 |
| E-mail: |
Medical.InformationU...eca.com
Medical.InformationUK@astrazeneca.com
|
| Internet: |
www.astrazeneca.com |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.12 |
| Free float: |
- |
| Data IPO: |
06.04.1999 |
